SRF News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of SRF Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: SRF Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news and updates on SRF from all sources in a single place.

SRF Ltd.

16 Dec 2025

3093.20

-0.27%

Company Update

SRF Ltd - 503806 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) …

BSE India

Pursuant to regulation 30 of SEBI (LODR) Regulations, 2015 read with Schedule III, Part-A, Para-B (Clause-8) we wish to inform the Stock exchanges about on Pending litigation/dispute

pdf

SRF Ltd.

15 Dec 2025

3093.20

-0.27%

Chemical segment uptick to improve H2 growth for chemicals maker SRF

Business Standard

Based on global chemical firms' outlook, analysts expect SRF to continue to benefit from strong volume-led recovery in agrochem globally, resilient R32 demand & modest demand growth outlook

SRF has gained 36.60% in the last 1 Year

SRF Ltd.

08 Dec 2025

3093.20

-0.27%

Upcycle across chemicals businesses; upside risk to consensus EPS

Buy: SRF Ltd.

Recommendation Target

ICICI Securities Limited

We remain sanguine on SRF’s chemicals business, with performance potentially improving across ref-gas, specialty chemicals and fluoropolymers. Higher volumes and sustained prices present ~15–20% upside risk in ref-gas business’ base-case revenues vs. a more plausible assessment.

SRF Ltd. is trading above all available SMAs

SRF Ltd.

25 Nov 2025

3093.20

-0.27%

Company Update

SRF Ltd - 503806 - Intimation Of Grant Of Options Under 'Part A - SRF Employees …

BSE India

Intimation of Grant of Options under ''Part-A- SRF Employees Stock Option Scheme, 2018 of SRF Long term Share based Incentives Plan, 2018 of the Company

pdf

SRF Ltd.

18 Nov 2025

3093.20

-0.27%

5 stocks to avoid in current market; SRF, Devyani, 3 more may dip up to 15%

Business Standard

SRF, Devyani, Sumitomo have witnessed the formation of 'Death Cross', while Sona Coms and PI Industries saw a negative crossover on the MACD indicator, show the stocks daily chart.

SRF Ltd. is trading above all available SMAs

SRF Ltd.

04 Nov 2025

3093.20

-0.27%

Earnings Call

SRF Ltd - 503806 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Earnings Call held on 28th October 2025

pdf

SRF Ltd.

03 Nov 2025

3093.20

-0.27%

SAST

SRF Ltd - 503806 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund

pdf

SRF Ltd.

31 Oct 2025

3093.20

-0.27%

SRF Ltd.

Buy: SRF Ltd.

Target

ICICI Direct

Q2FY26 Chemicals Business drives growth- Revenues grew 6% YoY to 3,534.5 crore driven by the Chemicals business (46% of the revenues) which reported a growth of 23% YoY to 1,667 crore. While technical textiles (13% of the revenue) and Packaging films (39% of revenues) reported a decline of 11% and 1% to 474.3 crore and 1,408 crore respectively. Consolidated EBITDA stood at 774.2 crore, up 44% YoY, translating to margins of 21.3%, up ~560 bps YoY driven by the Chemical business (EBIT) which stood at 29%, up ~1100 bps YoY. Moreover, PAT for...

Number of FII/FPI investors increased from 670 to 679 in Sep 2025 qtr.

SRF Ltd.

29 Oct 2025

3093.20

-0.27%

'Hold' SRF Shares Maintains Systematix Post Mixed Q2 Result, Trims Target Price; Sees Limited Upside Potential

NDTV Profit

While chemicals Ebit held the operating performance in line, the huge drag in packaging films business disappointed, adds the brokerage.

SRF Ltd. has an average target of 3367.11 from 10 brokers.

SRF Ltd.

29 Oct 2025, 08:19AM

3093.20

-0.27%

SRF's chemicals biz leads Q2 growth; analysts stay bullish; check targets

Business Standard

Brokerages maintained a positive stance on SRF, highlighting continued margin strength, steady volume growth, and the company's strategic capex expansion.